Analytical element and method for determination of theophylline by enzyme inhibition

• US 4,782,017 A
• Filed: 08/25/1986
• Issued: 11/01/1988
• Est. Priority Date: 08/25/1986
• Status: Expired due to Term

• Current Assignee: Clinical Diagnostic Systems Inc.
• Original Assignee: Eastman Kodak Company
• Inventors: Norton, Gary E., Frickey, Paul H.
• Primary Examiner(s): Kepplinger, Esther M.
• Application Number:
  US06/900,069
• Time in Patent Office: 799 Days
• Field of Search: 435/21, 435/184, 435/805, 435/810, 435/7, 436/825, 436/822
• US Class Current: 435/21
• CPC Class Codes: C12Q 1/42 involving phosphatase
• CPC Class Codes: C12Q 2334/10 p-Nitrophenol derivatives
• CPC Class Codes: G01N 33/526 the element being adapted for a specific analyte
• CPC Class Codes: Y10S 435/805 Test papers
• CPC Class Codes: Y10S 436/822 Identified hapten

Abstract

Theophylline can be determined with an analytical element and method which utilize the inhibition, by theophylline, of alkaline phosphatase activity on an appropriate substrate. The assay is carried out at a pH of 9 or less. The element comprises a porous spreading zone and at least one other zone in fluid contact with the spreading zone. The isoenzyme of alkaline phosphatase and a suitable substrate for the isoenzyme are located in different zones of the element. The element also contains a buffer for maintaining the pH at 9 or less, substantially all of which is located in the spreading zone.

Claims

1. A dry analytical element for the determination of theophylline comprising, in fluid contact, a porous spreading zone and at least one additional zone,

said element containing an isoenzyme of alkaline phosphatase which is capable of acting on a substrate for said isoenzyme at a pH of 9 or less, and a substrate for said isoenzyme, provided said phosphatase and substrate are in different zones of said element,

said element further containing a buffer which is capable of maintaining the pH at 9 or less during said determination, provided that substantially all of said buffer is in said porous spreading zone.

2. The element of claim 1 wherein said buffer is a nitrogen-containing organic buffer.

3. The element of claim 2 wherein said buffer is selected from the group consisting of tris(hydroxymethyl)aminomethane.HCl, glycylglycine, N-tris(hydroxymethyl)-methyl-2-aminoethanesulfonic acid and N-2-hydroxyethylpiperazine-N'"'"'-2-ethanesulfonic acid.

4. The element of claim 1 wherein said buffer is capable of maintaining the pH during said theophylline determination at from about 7 to about 9.

5. The element of claim 1 wherein said phosphatase substrate is in said spreading zone.

6. The element of claim 1 wherein said substrate is an organic mono- or diester of phosphoric acid and said phosphatase isoenzyme is bovine liver alkaline phosphatase.

7. An analytical element for the determination of theophylline comprising:

a support having thereon, in order and in fluid contact;

a first layer containing an isoenzyme of alkaline phosphatase which is capable of acting on a substrate for said isoenzyme at a pH of 9 or less,

a radiation-blocking layer, and

a porous spreading layer containing a substrate for said isoenzyme,

said element further containing a buffer which is capable of maintaining the pH at 9 or less during said determination, provided that substantially all of said buffer is in said porous spreading layer.

8. The element of claim 7 further comprising a subbing layer between said radiation-blocking and porous spreading layers.

9. The element of claim 7 wherein said porous spreading layer is a blush polymer spreading layer.

10. The element of claim 9 wherein said porous spreading layer comprises titanium dioxide.

11. The element of claim 7 wherein said substrate is selected from the group consisting of p-nitrophenyl phosphate and 4-(4-nitro-2-methlsulfonyl phenylazo)naphthol-1-phosphate, said alkaline phosphatase is bovine liver alkaline phosphatase, and said buffer is selected from the group consisting of tris(hydroxymethyl)aminomethane.HCl, glycylglycine, N-tris(hydroxymethyl)-methyl-2-aminoethanesulfonic acid and N-2-hydroxyethylpiperazine-N'"'"'-2-ethanesulfonic acid.

12. The element of claim 11 wherein said substrate is p-nitrophenyl phosphate and said buffer is tris(hydroxymethyl)aminomethane.HCl.

13. A method for the determination of theophylline comprising the steps of:

A. at a pH of 9 or less, contacting a sample of a biological fluid suspected of containing theophylline with a dry analytical element comprising, in fluid contact, a porous spreading zone and at least one additional zone,

said element containing an isoenzyme of alkaline phosphatase which is capable of acting on a substrate for said isoenzyme at a pH of 9 or less, and a substrate for said isoenzyme, provided said phosphatase and substrate are in different zones of said element,

said element further containing a buffer which is capable of maintaining the pH at 9 or less during said determination, provided that substantially all of said buffer is in said porous spreading zone, and

B. determining a detectable change resulting from said contact as an indication of the amount of theophylline in said biological fluids.

14. The method of claim 13 carried out at a pH of from about 7 to about 9.

15. The method of claim 13 wherein said biological fluid is human blood serum or whole blood.

16. A method for the determination of theophylline comprising the steps of:

A. at a pH of 9 or less, contacting a sample of a human biological fluid suspected of containing theophylline with a dry analytical element comprising;

a support having thereon, in order and in fluid contact;

a first layer containing an isoenzyme of alkaline phosphatase which is capable of acting on a substrate for said isoenzyme at a pH of 9 or less,

a radiation-blocking layer, and

a porous spreading layer containing a substrate for said isoenzyme,

said element further containing a buffer which is capable of maintaining the pH at 9 or less during said determination, provided that substantially all of said buffer is in said porous spreading layer, and

B. determining a detectable change resulting from said contact as an indication of the amount of theophylline in said human biological fluid.

17. The method of claim 16 carried out at a pH of from about 7 to about 9.

18. The method of claim 16 wherein said human biological fluid is blood serum or whole blood.